Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360900 · ClinicalTrials.gov registry record · NA
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
A NA study of Functional Dyspepsia, sponsored by Spaulding Rehabilitation Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06360900 is a NA study of Functional Dyspepsia that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 80 participants, above the 64-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (25% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06360900, a NA study of Functional Dyspepsia, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- DEVICE Sensory device
- BEHAVIORAL Skills Building
- DEVICE Subsensory device
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-10-29 |
| Est. Completion | 2029-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06360900
The ClinicalTrials.gov registry entry for NCT06360900 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (25% higher). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Functional Dyspepsia appearing as the primary indexed condition, and to 4 interventions - of which Health Education is the first listed.
NCT06360900 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06360900 about?
NCT06360900 is a clinical study titled "Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia". The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.
What is the current status of trial NCT06360900?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-10-29. Estimated completion is 2029-03.
What conditions does trial NCT06360900 study?
This clinical trial studies the following conditions: Functional Dyspepsia.
What interventions are being tested in trial NCT06360900?
The interventions under investigation include: Health Education (BEHAVIORAL), Sensory device (DEVICE), Skills Building (BEHAVIORAL), Subsensory device (DEVICE).
Who is sponsoring clinical trial NCT06360900?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06360900 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Autonomic Reactivity and Personalized Neurostimulation
RECRUITING · NA
-
Functional Dyspepsia Treatment Using Virtual Reality
RECRUITING · NA
-
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
RECRUITING · NA
-
Cerebral Cortical Influences on Autonomic Function
ACTIVE NOT RECRUITING · NA
-
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.